Clinical trialNCT01156090CompletedObservational

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

SponsorSCRI Development Innovations, LLCEnrollment141Infusion Reaction

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to identify approximately 100 - 150 patients who have received Vectibix (Panitumumab) in offices and clinics located in Tennessee, North Carolina, South Carolina, and North Georgia from February 2004 - April 2009. Information regarding the incidence and severity of hypersensitivity infusion reactions to Vectibix (Panitumumab)will be captured. In patients who experienced hypersensitivity reactions, the following information will also be collected: premedication, treatment cycle symptoms that were experienced during chemotherapy, changes required in subsequent Vectibix (Panitumumab) or chemotherapy treatment, and outcome of the hypersensitivity reaction.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Nancy Peacock, M.D.
SCRI Development Innovations, LLC
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
Medical Oncology Associates of Augusta
Augusta, Georgia, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
Baptist Hospital East
Louisville, Kentucky, United States
St. Louis Cancer Care
Chesterfield, Missouri, United States
South Carolina Oncology Associates, Pa
Columbia, South Carolina, United States
Tennessee Oncology, Pllc
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2010
Primary completion: 31 Dec 2012
Completion: 31 Jan 2013
Last update posted: 28 Aug 2015
Registered enrollment: 141
Registry id: NCT01156090

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.